Dayi Therapeutics Inc.
New York, NY
- UEI
- EGQ3LAQJS311
- CAGE
- Not on record
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 3960 Broadway, New York, NY 10032, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Developing RNA therapeutics for rare neurodevelopmental disorders | National Institute of Child Health and Human Development (NIH) | $4,560,681 |
Quick answers
Is Dayi Therapeutics Inc. registered in SAM.gov?
Yes. Dayi Therapeutics Inc.'s SAM.gov registration is active through October 23, 2026.
What is Dayi Therapeutics Inc.'s most recent federal award?
Dayi Therapeutics Inc.'s most recent federal grant award is Developing RNA therapeutics for rare neurodevelopmental disorders (R42HD111138), from National Institute of Child Health and Human Development (NIH), on May 1, 2023.
On GovTribe
See Dayi Therapeutics Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors